About Recuro Health

Recuro Health is an integrated digital health solution that evolves healthcare from a reactive, disease-focused model to a personalized, proactive system. Recuro’s virtual health platform consists of a curated suite of digital solutions—from primary care and behavioral health to at-home testing and genetic screening. Fully customizable, these solutions can be tailored to meet the needs of any population, allowing patients to engage with physicians, receive more personalized care, and monitor their own health, no matter their location or circumstance. With streamlined information exchange between primary care and behavioral health teams as well as testing and screening tools, Recuro’s virtual health platform enables the delivery of coordinated, holistic care that ultimately results in better outcomes at a lower cost.

Recuro healthcare solutions occur at the intersection of quality, access and affordability, delivering appropriate care at the right time and place. We empower earlier and more efficient interventions, supplement in-person care, and provide a true mosaic of each member’s health and the efficacy of past interventions.

By evaluating outcomes and compliance together, the Recuro platform minimizes the need for acute, episodic care by providing the digital keys to member health.  These combined assets provide appropriate referrals and recommendations that contribute to better patient engagement, enhanced outcomes and reduced costs.

Leadership

Disrupting the traditional healthcare delivery system by bridging the gap between the current system and digital health, Recuro is led by Michael Gorton, founding CEO of Teladoc.  The Recuro team includes several Teladoc leaders along with other healthcare luminaries and experienced business executives such as Jay Sanders, MD, founder of the American Telemedicine Association and acknowledged as the ‘Father of Telemedicine.’

These experienced healthcare executives and clinicians have a deep understanding of the current challenges facing healthcare systems and are building the infrastructure and partnerships to address challenges that include care fragmentation, gaps in care, poor outcomes and high costs and more.  Collectively, these issues make healthcare unsustainable but create a fertile opportunity for the changes that Recuro brings to all stakeholders.

Business Model

We are executing this vision by integrating high-impact digital health solutions across the full patient journey, from well care to pre-acute and acute care to post-acute care. With robust funding, we are leveraging a roll-up strategy that will result in 500,000 members and $15.0MM+ in revenue by the end of the 2021.

Want to learn more? Contact Us.

Michael Gorton
Chief Executive Officer

John Halsey
Chief Growth Officer

Michael Brombach
Chief Product Officer

Allison Martin
Executive Director

Gina Fioretti
Executive Director, Genomics

Stephen Hochschuler, MD
Chief Medical Officer

Delta Variant, Stalled Vaccination Rates, New Directives from Federal/State Governments, CDC and Employers Increase Demand for Recuro’s At-Home & In-office COVID Testing Solution

August 2, 2021

‘Vaccinate or Get Tested’ is the new policy from all corners of government and private industry amid the surge of the Delta variant, recurrence of…

Read More...

Spotlight Interview: John Halsey, Chief Growth Officer, Recuro & Michael Brombach, Executive Director, Recuro

July 28, 2021

Medical Travel & Digital Health News (MTDHN):  First, tell our readers why Recuro’s COVID-19 PCR rapid testing is a vital component of every employer’s back-to-work…

Read More...

Recuro’s At-Home Testing Expert Shares “Best Practices” and Industry Future at American Telemedicine Association’s 2021 Conference

July 26, 2021

Allison Martin, a founder and executive director of Recuro Health, recently joined a panel at the American Telemedicine Association’s annual conference to talk about emerging…

Read More...

Recuro Acquires Genomics Risk Stratification Tool: Expanding Capabilities for Personalized Care and Streamlining Full Continuum of Care

July 20, 2021

Genetic testing has been available for several years. Consumer genomics is very popular now with the medically focused use of genetic testing growing rapidly at…

Read More...